Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Infectious disease · Phase I

Infectious disease programs at Phase I — ClinicalTrials.gov pipeline intelligence.

Programs 237

Quick answer

Infectious disease Phase I programs: NovaPharmaNews indexes 237 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

Page 4 of 5

  1. MP-424 (Telaprevir)

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  2. MPT0B640

    INTENSITY THERAPEUTICS, INC.

    Covid19

    phase 1 small molecule terminated

    1 trial

  3. MSC-derived exosomes

    Regeneron Ireland Designated Activity Company (DAC)

    Long COVID-19 Syndrome

    phase 1 mab active

    1 trial

  4. MSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 1 mab active

    1 trial

  5. MV-LASV

    Harmony Biosciences Holdings

    Lassa Virus Infection

    phase 1 mab completed

    1 trial

  6. Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

    ViiV Healthcare Pty Ltd

    human immunodeficiency virus (HIV)

    phase 1 other active

    1 trial

  7. Midazolam

    Hoffmann-La Roche

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  8. Mino-PK

    Disc Medicine

    Nontuberculous mycobacterial disease

    phase 1 other active

    1 trial

  9. Miricorilant

    CORCEPT THERAPEUTICS INC

    Non-alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  10. Miricorilant 150 mg

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  11. NCO-48 Fumarate

    LIGAND PHARMACEUTICALS INC

    Hepatitis B

    phase 1 small molecule completed

    1 trial

  12. NCO-48 Fumarate 4 mg

    LIGAND PHARMACEUTICALS INC

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial

  13. NDV-3 vaccine with alum IM

    United Therapeutics Europe Ltd

    Staphylococcal Infections

    phase 1 mab completed

    1 trial

  14. Nevirapine

    Teva Pharma GmbH

    HIV-1

    phase 1 small molecule completed

    1 trial

  15. Nezulcitinib (TD-0903) Dose A

    Theravance Biopharma Ireland Umited

    Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)

    phase 1 small molecule completed

    1 trial

  16. Novel Supplement Based Therapy

    Atrium Therapeutics

    Small Intestinal Bacterial Overgrowth

    phase 1 other terminated

    1 trial

  17. One dose of investigational vaccine

    Sinovac Research and Development Co.,

    Hepatitis B

    phase 1 mab completed

    1 trial

  18. Ontamalimab

    Takeda

    Steatohepatitis

    phase 1 small molecule terminated

    1 trial

  19. P3C541b Lipopeptide

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  20. PBGENE-HBV

    Chongqing Precision Biotech Co., Ltd

    HEPATITIS B CHRONIC

    phase 1 mab active

    1 trial

  21. PBGENE-HBV-01

    Chongqing Precision Biotech Co., Ltd

    Chronic Hepatitis B

    phase 1 other active

    1 trial

  22. PCV-LITE-I

    Teva Pharma GmbH

    Pneumococcal infection

    phase 1 other active

    1 trial

  23. PEGylated recombinant human interferon alpha-2b injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    phase 1 small molecule active

    1 trial

  24. PENNVAX-B

    INOVIO PHARMACEUTICALS, INC.

    HIV-1 Infection

    phase 1 mab completed

    1 trial

  25. PMV via Puffhaler® device

    Serum Life Science Europe GmbH

    Prophylaxis for the Measles Infection

    phase 1 mab completed

    1 trial

  26. PRO 2000/5 Gel (P)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 1 small molecule completed

    1 trial

  27. PTC:VS-TC

    Istituto Gentili S.r.l.

    Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.

    phase 1 other active

    1 trial

  28. PegInterferon

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  29. Peginterferon lambda

    Biotech Pharmaceutical Co.,

    Hepatitis C

    phase 1 mab completed

    1 trial

  30. Peldesine

    Biocryst

    HIV Infections

    phase 1 small molecule completed

    1 trial

  31. Peptides (N,R&C) formulated in Montanide ISA 720

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria, Vivax

    phase 1 small molecule completed

    1 trial

  32. Pevifoscorvir Sodium (ALG-000184)

    Aligos Therapeutics

    Chronic Hepatitis B Infection

    phase 1 small molecule active

    1 trial

  33. Pevifoscorvir Sodium (ALG-000184)

    Aligos Therapeutics

    Chronic Hepaititis B Infections

    phase 1 small molecule active

    1 trial

  34. Pharmacokinetic study of colistimethate sodium

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options

    phase 1 other active

    1 trial

  35. Placebo

    Pfizer

    Respiratory Syncytial Virus Infections

    phase 1 small molecule terminated

    1 trial

  36. Placebo gelatin pill

    Universal Integrated

    Vaginosis, Bacterial

    phase 1 small molecule completed

    1 trial

  37. Plasmodium falciparum Malaria Protein 010 (FMP010)

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  38. Pneumococcal Vaccine, Polyvalent (23-valent)

    Praxis Precision Medicines

    HIV Infections

    phase 1 mab completed

    1 trial

  39. Protrans V

    Lacuna Pharma Pty Ltd

    Respiratory viral disease, COVID-19, Influenza A, Metapneumovirus, Respiratory syncytial virus Infection

    phase 1 other active

    1 trial

  40. Q-Griffithsin

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule completed

    1 trial

  41. Q-Griffithsin 3.0

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule active

    1 trial

  42. QLS1128 A-Dose 1~5 and Ritonavir

    Qilu Pharmaceutical (Hainan) Co.,

    COVID-19

    phase 1 small molecule active

    1 trial

  43. REC611-IIT-1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

  44. Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 1 mab completed

    1 trial

  45. Recombinant SARS-CoV-2 Fusion Protein Vaccine

    Livzon Pharmaceutical Group

    COVID19

    phase 1 mab completed

    1 trial

  46. SA55 Injection

    Sinovac Research and Development Co.,

    COVID-19

    phase 1 small molecule active

    1 trial

  47. SA55 nasal spray

    Sinovac Research and Development Co.,

    COVID-19

    phase 1 small molecule active

    1 trial

  48. SAB-185

    SAB Biotherapeutics

    COVID-19

    phase 1 mab active

    2 trials

Frequently asked questions

How many infectious disease Phase I programs exist?

237 programs match both the therapeutic area and stage filters in our published index.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.